As it was also shown that high Cyr61 levels are associated with a more-aggressive breast cancer phenotype, this supports the idea of a selection process in vivo, which finally leads to aggressive phenotypes with high Cyr61 expression [27]. This evidence concerns the gene CCN1 and breast cancer.